Cochrane Abstracts
Second‐line chemotherapy for non‐small cell lung cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Second‐line Chemotherapy for Non‐small Cell Lung Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433361/all/Second‐line_chemotherapy_for_non‐small_cell_lung_cancer.
Second‐line chemotherapy for non‐small cell lung cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433361/all/Second‐line_chemotherapy_for_non‐small_cell_lung_cancer. Accessed December 21, 2024.
Second‐line chemotherapy for non‐small cell lung cancer. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433361/all/Second‐line_chemotherapy_for_non‐small_cell_lung_cancer
Second‐line Chemotherapy for Non‐small Cell Lung Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433361/all/Second‐line_chemotherapy_for_non‐small_cell_lung_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Second‐line chemotherapy for non‐small cell lung cancer
ID - 433361
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433361/all/Second‐line_chemotherapy_for_non‐small_cell_lung_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
